Citadel Advisors’s Innovator US Equity Accelerated 9 Buffer ETF October XBOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27,987
Closed -$918K 14263
2025
Q3
$918K Buy
27,987
+20,032
+252% +$648K ﹤0.01% 7714
2025
Q2
$253K Buy
7,955
+622
+8% +$18.8K ﹤0.01% 10183
2025
Q1
$218K Buy
7,333
+109
+2% +$3.31K ﹤0.01% 10286
2024
Q4
$218K Buy
7,224
+131
+2% +$3.94K ﹤0.01% 10292
2024
Q3
$211K Buy
7,093
+1
+0% +$29 ﹤0.01% 10035
2024
Q2
$208K Sell
7,092
-4,764
-40% -$138K ﹤0.01% 9852
2024
Q1
$341K Hold
11,856
﹤0.01% 9200
2023
Q4
$330K Buy
+11,856
New +$319K ﹤0.01% 8973
2023
Q3
Sell
-197,493
Closed -$5.08M 15233
2023
Q2
$5.08M Buy
197,493
+163,351
+478% +$4.1M ﹤0.01% 3618
2023
Q1
$839K Sell
34,142
-2,933
-8% -$70.6K ﹤0.01% 7178
2022
Q4
$860K Buy
37,075
+16,023
+76% +$368K ﹤0.01% 7100
2022
Q3
$464K Buy
+21,052
New +$493K ﹤0.01% 8632

Other funds holding XBOC

Citadel Advisors's XBOC Position: Q4 2025 in Review

Citadel Advisors sold out of Innovator US Equity Accelerated 9 Buffer ETF October (XBOC) in Q4 2025, closing a stake of 27,987 shares — an estimated $918K sold.

Citadel Advisors first reported a position in XBOC in Q3 2022 and held it in 12 quarters. The position peaked at $5.08M in Q2 2023. 48 funds tracked by Wall St. Rank hold XBOC as of Q4 2025.

  • Citadel Advisors reported no remaining Innovator US Equity Accelerated 9 Buffer ETF October position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 27,987 Innovator US Equity Accelerated 9 Buffer ETF October shares in Q4 2025, an estimated $918K.
  • Citadel Advisors first reported a position in Innovator US Equity Accelerated 9 Buffer ETF October in Q3 2022 and held it in 12 quarters.
  • Citadel Advisors's Innovator US Equity Accelerated 9 Buffer ETF October position peaked at $5.08M in Q2 2023.
  • 48 funds tracked by Wall St. Rank held Innovator US Equity Accelerated 9 Buffer ETF October as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.